The country sent a message: these kinds of opportunities have come

These varieties have the opportunity to come to the State Administration of traditional Chinese medicine and release 95 clinical paths of traditional Chinese medicine Recently, Inner Mongolia health and Health Committee forwarded the notice on the implementation of clinical paths of traditional Chinese medicine and the treatment plan of traditional Chinese medicine for 95 dominant diseases of traditional Chinese medicine such as rheumatism, pulmonary fever (severe pneumonia) by the office of the State Administration of traditional Chinese medicine (hereinafter referred to as the notice) According to the notice, in order to ensure the quality and safety of medical treatment, the State Administration of traditional Chinese medicine continued to promote the management of clinical pathway, entrusted the Chinese society of traditional Chinese medicine to organize experts to formulate the clinical pathway and Chinese medical diagnosis and treatment scheme (2018 version) of 95 dominant diseases of traditional Chinese medicine, such as rheumatic pulmonary fever (severe pneumonia), for the reference of medical institutions In the published clinical path and diagnosis and treatment plan, it should be noted that when cypress blue inquires the 95 plans published this time, it is found that after each diagnosis and treatment plan of traditional Chinese medicine, a sentence "or proprietary Chinese medicine with similar efficacy (including traditional Chinese medicine injection)" will be added basically This means that in the clinical pathway of 95 common diseases, Chinese patent medicines with the same efficacy as traditional Chinese medicine will usher in opportunities Cypress blue combed out the clinical path and diagnosis and treatment plan of several common diseases, and combed out the relevant varieties Cough disease wind cold attack lung syndrome - Recommended prescription: Sanao decoction combined with Zhisou powder Syndrome of wind heat invading lung - Recommended prescription: addition and subtraction of Sangju decoction Syndrome of dryness and pathogenic invasion of lung - Recommended prescription: addition and subtraction of sangxing decoction Phlegm heat damming lung syndrome - Recommended prescription: addition and subtraction of Qingjin Huatan Decoction Phlegm dampness blocking lung syndrome - Recommended prescription: Erchen decoction and Sanzi Yangqin decoction Chtv Health China once classified cough and listed the recommended drugs, all of which are Chinese patent medicines Hot cough: Sangju cold tablet, Chuanbei loquat dew, Hedan Chuanbei loquat cream; cold cough: tongxuanlifei pill, Sanao tablet, zhikebao tablet; dry cough: Baihe Gujin tablet, Chuanbei Qingfei syrup, Yangyin Qingfei oral liquid; fengke: Suhuang Zhike capsule The basic prescription of HFMD: Lingjiao Gouteng Decoction Antelope horn powder (prepared), uncaria, gastrodia, gypsum, Coptis, gardenia, rhubarb, chrysanthemum, coix seed, scorpion, white Bombyx mori, oyster Or traditional Chinese medicine with similar efficacy (including traditional Chinese medicine injection) can be used In the paper "commonly used oral Chinese patent medicine preparations for the treatment of hand, foot and mouth disease", researcher Meng Xianmin, Shen Li and others said that the Chinese patent medicine used for the treatment of hand, foot and mouth disease can be divided into two categories: oral preparations and injection The common type patients mostly use oral preparations mainly for clearing heat, while the heavy and critical type patients need to use injection with detoxification and recovery of Yang The oral preparations for clearing away heat and detoxifying mainly include Jinlian Qingre effervescent tablet, antiviral oral liquid, Jinzhen oral liquid, lancen oral liquid and Xiaoer daiqiaoqingre granules, etc the injection with the effect of detoxifying and returning Yang mainly includes Xiyanping injection, Reduning injection, Tanreqing injection, Xingnaojing injection, Shenfu injection and Shengmai injection There are also clinical routes and adjuvant drugs, which are dangerous Nowadays, the problem of irrational drug use is very prominent in the world According to the data, more than 50% of the drugs in the world are improperly prescribed, dispensed or sold, and 50% of the patients do not use the drugs correctly, and 30% of the deaths are caused by unreasonable use of drugs Among them, according to the health newspaper, the rate of irrational drug use in China is 12% - 32% About 10 of the 50 million inpatients in China die every year Therefore, it is very important to include medication management in clinical pathway, which can curb the rising medical costs and improve the utilization rate of health resources The major impact is auxiliary medication: if the clinical diagnosis pathway is strictly implemented in hospitals at all levels, under the background of reducing the cost of drugs and drugs, it is inevitable to strengthen the auxiliary medication management Love It is understood that the clinical pathway can effectively improve and unify the treatment plan and treatment process of various diseases at all levels of hospitals, and it also has the significance of training, popularization and standardization for doctors at grass-roots and low-level hospitals At the same time, it will affect the life and death of many drugs - because without the clinical pathway, doctors cannot be prescribed The national attention to clinical pathway is obvious In May 2017, the health and Health Commission released the news that it planned to carry out clinical pathway management in three-level hospitals in an all-round way In December 2016, the national health and Family Planning Commission issued the notice of the general office of the national health and Family Planning Commission on the implementation of the clinical pathway of related diseases 1010 clinical pathways were published on the website of the Chinese Medical Association for the reference of the health and family planning administrative departments and medical institutions In 2015, the National Health Commission issued the notice on printing and distributing the action plan for further improvement of medical services, which proposed to vigorously promote the clinical pathway With the continuous launch of clinical pathway scheme, the catalogue of auxiliary drugs will be published soon How to draw on and implement the guidance scientifically, and how to avoid all kinds of commonly used clinical drugs being kicked out of the market due to the tendency of drug use in the formulation of some clinical pathways have become the issues that every pharmaceutical enterprise needs to consider.